Period:
Draw Mode:
| Volume | 400,134 |
|
|||||
| News | - | ||||||
| Day High | 2.34 | Low High |
|||||
| Day Low | 2.11 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Stereotaxis Inc | STXS | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.45% | 2.21 | 18:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.19 | 2.11 | 2.34 | 2.27 | 2.20 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,059 | 400,134 | $ 2.25 | $ 900,722 | - | 1.55 - 2.7452 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:59:39 | 2 | $ 2.31 | USD |
Stereotaxis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 178.30M | 80.68M | 66.77M | $ 4.73M | $ -53.42k | -0.07 | -3,337.99 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | - |
Stereotaxis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STXS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.06 | 2.34 | 2.02 | 2.16 | 184,817 | 0.15 | 7.28% |
| 1 Month | 1.76 | 2.38 | 1.605 | 2.09 | 498,663 | 0.45 | 25.57% |
| 3 Months | 2.32 | 2.38 | 1.605 | 2.00 | 276,586 | -0.11 | -4.74% |
| 6 Months | 2.36 | 2.7452 | 1.605 | 2.12 | 228,886 | -0.15 | -6.36% |
| 1 Year | 2.25 | 2.7452 | 1.55 | 2.08 | 259,968 | -0.04 | -1.78% |
| 3 Years | 4.17 | 10.30 | 1.55 | 4.66 | 301,140 | -1.96 | -47.0% |
| 5 Years | 3.06 | 10.30 | 1.55 | 4.56 | 288,961 | -0.85 | -27.78% |
Stereotaxis Description
| Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States. |